Industries from around the world spent nearly $1 billion to lobby the federal government during the first quarter of this year, according to a new analysis by the Center for Responsive Politics — the highest in five years.
The uptick was driven by both optimism and fear over the priorities of President Trump and the Republican Congress, lobbying experts said. However, nervous drugmakers logged their biggest increase in spending amid signs that the new president may try to drive down drug prices.